Cryo-Cell International, Inc. (FRA:ZCY)

Germany flag Germany · Delayed Price · Currency is EUR
3.560
+0.160 (4.71%)
Last updated: Nov 26, 2025, 9:59 AM CET
-55.78%
Market Cap27.58M
Revenue (ttm)27.14M
Net Income (ttm)-404.85K
Shares Outn/a
EPS (ttm)-0.05
PE Ration/a
Forward PEn/a
Dividend0.37 (10.47%)
Ex-Dividend DateMay 21, 2025
Volumen/a
Average Volumen/a
Open3.560
Previous Close3.400
Day's Range3.560 - 3.560
52-Week Range2.920 - 8.750
Betan/a
RSI40.98
Earnings DateFeb 27, 2026

About Cryo-Cell International

Cryo-Cell International, Inc. engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells, which are used in regenerative medicine to treat a range of conditions. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell pr... [Read more]

Industry Miscellaneous Health And Allied Services, Not Elsewhere Classified
Founded 1989
Employees 86
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol ZCY
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.